O	0	1	A	A	DT	B-NP
O	2	7	STAT3	STAT3	NN	I-NP
O	7	8	-	-	HYPH	B-VP
O	8	16	mediated	mediate	VBN	I-VP
O	17	26	metabolic	metabolic	JJ	B-NP
O	27	33	switch	switch	NN	I-NP
O	34	36	is	be	VBZ	B-VP
O	37	45	involved	involve	VBN	I-VP
O	46	48	in	in	IN	B-PP
B-Cancer	49	55	tumour	tumour	NN	B-NP
O	56	70	transformation	transformation	NN	I-NP
O	71	74	and	and	CC	O
O	75	80	STAT3	STAT3	NN	B-NP
O	81	90	addiction	addiction	NN	I-NP
O	90	91	.	.	.	O

O	93	96	The	The	DT	B-NP
O	97	100	pro	pro	AFX	I-NP
O	100	101	-	-	HYPH	I-NP
O	101	110	oncogenic	oncogenic	JJ	I-NP
O	111	124	transcription	transcription	NN	I-NP
O	125	131	factor	factor	NN	I-NP
O	132	137	STAT3	STAT3	NN	I-NP
O	138	140	is	be	VBZ	B-VP
O	141	155	constitutively	constitutively	RB	I-VP
O	156	165	activated	activate	VBN	I-VP
O	166	168	in	in	IN	B-PP
O	169	170	a	a	DT	B-NP
O	171	175	wide	wide	JJ	I-NP
O	176	183	variety	variety	NN	I-NP
O	184	186	of	of	IN	B-PP
B-Cancer	187	194	tumours	tumour	NNS	B-NP
O	195	199	that	that	WDT	B-NP
O	200	205	often	often	RB	B-ADVP
O	206	212	become	become	VBP	B-VP
O	213	221	addicted	addict	VBN	I-VP
O	222	224	to	to	TO	B-PP
O	225	228	its	its	PRP$	B-NP
O	229	237	activity	activity	NN	I-NP
O	237	238	,	,	,	O
O	239	242	but	but	CC	O
O	243	245	no	no	DT	B-NP
O	246	254	unifying	unifying	JJ	I-NP
O	255	259	view	view	NN	I-NP
O	260	262	of	of	IN	B-PP
O	263	264	a	a	DT	B-NP
O	265	269	core	core	NN	I-NP
O	270	278	function	function	NN	I-NP
O	279	290	determining	determine	VBG	B-VP
O	291	295	this	this	DT	B-NP
O	296	306	widespread	widespread	JJ	I-NP
O	307	312	STAT3	STAT3	NN	I-NP
O	312	313	-	-	HYPH	B-NP
O	313	323	dependence	dependence	NN	I-NP
O	324	327	has	have	VBZ	B-VP
O	328	331	yet	yet	RB	I-VP
O	332	339	emerged	emerge	VBN	I-VP
O	339	340	.	.	.	O

O	341	343	We	We	PRP	B-NP
O	344	348	show	show	VBP	B-VP
O	349	353	here	here	RB	B-NP
O	354	358	that	that	IN	B-SBAR
O	359	373	constitutively	constitutively	RB	B-NP
O	374	380	active	active	JJ	I-NP
O	381	386	STAT3	STAT3	NN	I-NP
O	387	391	acts	act	VBZ	B-VP
O	392	394	as	as	IN	B-PP
O	395	396	a	a	DT	B-NP
O	397	403	master	master	NN	I-NP
O	404	413	regulator	regulator	NN	I-NP
O	414	416	of	of	IN	B-PP
B-Cell	417	421	cell	cell	NN	B-NP
O	422	432	metabolism	metabolism	NN	I-NP
O	432	433	,	,	,	O
O	434	442	inducing	induce	VBG	B-VP
O	443	450	aerobic	aerobic	JJ	B-NP
O	451	461	glycolysis	glycolysis	NN	I-NP
O	462	465	and	and	CC	O
O	466	470	down	down	RB	B-ADVP
O	470	471	-	-	HYPH	O
O	471	481	regulating	regulate	VBG	B-VP
B-Cellular_component	482	495	mitochondrial	mitochondrial	JJ	B-NP
O	496	504	activity	activity	NN	I-NP
O	505	509	both	both	CC	B-PP
O	510	512	in	in	IN	B-PP
O	513	520	primary	primary	JJ	B-NP
B-Cell	521	532	fibroblasts	fibroblast	NNS	I-NP
O	533	536	and	and	CC	B-PP
O	537	539	in	in	IN	B-PP
O	540	545	STAT3	STAT3	NN	B-NP
O	545	546	-	-	HYPH	B-NP
O	546	555	dependent	dependent	JJ	I-NP
B-Cell	556	562	tumour	tumour	NN	I-NP
I-Cell	563	567	cell	cell	NN	I-NP
I-Cell	568	573	lines	line	NNS	I-NP
O	573	574	.	.	.	O

O	575	577	As	As	IN	B-PP
O	578	579	a	a	DT	B-NP
O	580	586	result	result	NN	I-NP
O	586	587	,	,	,	O
B-Cell	588	593	cells	cell	NNS	B-NP
O	594	597	are	be	VBP	B-VP
O	598	607	protected	protect	VBN	I-VP
O	608	612	from	from	IN	B-PP
O	613	622	apoptosis	apoptosis	NN	B-NP
O	623	626	and	and	CC	I-NP
O	627	637	senescence	senescence	NN	I-NP
O	638	643	while	while	IN	B-SBAR
O	644	652	becoming	become	VBG	B-VP
O	653	659	highly	highly	RB	B-ADJP
O	660	669	sensitive	sensitive	JJ	I-ADJP
O	670	672	to	to	TO	B-PP
O	673	680	glucose	glucose	NN	B-NP
O	681	692	deprivation	deprivation	NN	I-NP
O	692	693	.	.	.	O

O	694	696	We	We	PRP	B-NP
O	697	701	show	show	VBP	B-VP
O	702	706	that	that	IN	B-SBAR
O	707	715	enhanced	enhance	VBN	B-NP
O	716	726	glycolysis	glycolysis	NN	I-NP
O	727	729	is	be	VBZ	B-VP
O	730	739	dependent	dependent	JJ	B-ADJP
O	740	742	on	on	IN	B-PP
O	743	746	HIF	HIF	NN	B-NP
O	746	747	-	-	HYPH	I-NP
O	747	753	1alpha	1alpha	NN	I-NP
O	754	756	up	up	RB	B-ADVP
O	756	757	-	-	HYPH	B-NP
O	757	767	regulation	regulation	NN	I-NP
O	767	768	,	,	,	O
O	769	774	while	while	IN	B-SBAR
O	775	782	reduced	reduce	VBN	B-NP
B-Cellular_component	783	796	mitochondrial	mitochondrial	JJ	I-NP
O	797	805	activity	activity	NN	I-NP
O	806	808	is	be	VBZ	B-VP
O	809	812	HIF	HIF	NN	B-NP
O	812	813	-	-	HYPH	B-NP
O	813	819	1alpha	1alpha	NN	I-NP
O	819	820	-	-	HYPH	O
O	820	831	independent	independent	JJ	B-ADJP
O	832	835	and	and	CC	O
O	836	842	likely	likely	RB	B-VP
O	843	849	caused	cause	VBN	I-VP
O	850	852	by	by	IN	B-PP
O	853	858	STAT3	STAT3	NN	B-NP
O	858	859	-	-	HYPH	O
O	859	867	mediated	mediate	VBN	B-VP
O	868	872	down	down	RB	B-ADVP
O	872	873	-	-	HYPH	B-NP
O	873	883	regulation	regulation	NN	I-NP
O	884	886	of	of	IN	B-PP
B-Cellular_component	887	900	mitochondrial	mitochondrial	JJ	B-NP
O	901	909	proteins	protein	NNS	I-NP
O	909	910	.	.	.	O

O	911	914	The	The	DT	B-NP
O	915	924	induction	induction	NN	I-NP
O	925	927	of	of	IN	B-PP
O	928	935	aerobic	aerobic	JJ	B-NP
O	936	946	glycolysis	glycolysis	NN	I-NP
O	947	949	is	be	VBZ	B-VP
O	950	952	an	an	DT	B-NP
O	953	962	important	important	JJ	I-NP
O	963	972	component	component	NN	I-NP
O	973	975	of	of	IN	B-PP
O	976	981	STAT3	STAT3	NN	B-NP
O	982	985	pro	pro	AFX	O
O	985	986	-	-	HYPH	O
O	986	995	oncogenic	oncogenic	JJ	B-NP
O	996	1006	activities	activity	NNS	I-NP
O	1006	1007	,	,	,	O
O	1008	1013	since	since	IN	B-PP
O	1014	1024	inhibition	inhibition	NN	B-NP
O	1025	1027	of	of	IN	B-PP
O	1028	1033	STAT3	STAT3	NN	B-NP
O	1034	1042	tyrosine	tyrosine	NN	I-NP
O	1043	1058	phosphorylation	phosphorylation	NN	I-NP
O	1059	1061	in	in	IN	B-PP
O	1062	1065	the	the	DT	B-NP
B-Cell	1066	1072	tumour	tumour	NN	I-NP
I-Cell	1073	1077	cell	cell	NN	I-NP
I-Cell	1078	1083	lines	line	NNS	I-NP
O	1084	1088	down	down	RB	B-ADVP
O	1088	1089	-	-	HYPH	B-NP
O	1089	1098	regulates	regulate	VBZ	B-VP
O	1099	1109	glycolysis	glycolysis	NN	B-NP
O	1110	1115	prior	prior	JJ	B-ADJP
O	1116	1118	to	to	TO	B-PP
O	1119	1126	leading	lead	VBG	B-VP
O	1127	1129	to	to	TO	B-PP
O	1130	1136	growth	growth	NN	B-NP
O	1137	1143	arrest	arrest	NN	I-NP
O	1144	1147	and	and	CC	O
B-Cell	1148	1152	cell	cell	NN	B-NP
O	1153	1158	death	death	NN	I-NP
O	1158	1159	,	,	,	O
O	1160	1164	both	both	CC	O
O	1165	1167	in	in	FW	B-ADVP
O	1168	1173	vitro	vitro	FW	I-ADVP
O	1174	1177	and	and	CC	O
O	1178	1180	in	in	FW	B-ADVP
O	1181	1185	vivo	vivo	FW	I-ADVP
O	1185	1186	.	.	.	O

O	1187	1189	We	We	PRP	B-NP
O	1190	1197	propose	propose	VBP	B-VP
O	1198	1202	that	that	IN	B-SBAR
O	1203	1207	this	this	DT	B-NP
O	1208	1213	novel	novel	JJ	I-NP
O	1213	1214	,	,	,	I-NP
O	1215	1222	central	central	JJ	I-NP
O	1223	1232	metabolic	metabolic	JJ	I-NP
O	1233	1237	role	role	NN	I-NP
O	1238	1240	is	be	VBZ	B-VP
O	1241	1243	at	at	IN	B-PP
O	1244	1247	the	the	DT	B-NP
O	1248	1252	core	core	NN	I-NP
O	1253	1255	of	of	IN	B-PP
O	1256	1259	the	the	DT	B-NP
O	1260	1269	addiction	addiction	NN	I-NP
O	1270	1273	for	for	IN	B-PP
O	1274	1279	STAT3	STAT3	NN	B-NP
O	1280	1285	shown	show	VBN	B-VP
O	1286	1288	by	by	IN	B-PP
O	1289	1291	so	so	RB	B-NP
O	1292	1296	many	many	JJ	I-NP
O	1297	1309	biologically	biologically	RB	I-NP
O	1310	1319	different	different	JJ	I-NP
B-Cancer	1320	1327	tumours	tumour	NNS	I-NP
O	1327	1328	.	.	.	O

